Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
暂无分享,去创建一个
J. Hainsworth | L. Pickering | A. Armstrong | I. Puzanov | C. Ryan | C. Lusk | J. Picus | W. Stadler | Jorge A. Garcia | D. George | C. Kollmannsberger | Robert J. Jones | U. Vaishampayan | R. Hawkins | S. Halabi | T. Eisen | A. Protheroe | T. Logan | S. Broderick | Sadie Oberg